Impact of neighborhood-level COVID-19 mortality on the increase in drug overdose mortality in New York City during the COVID-19 pandemic.

IF 2.4 3区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Injury Epidemiology Pub Date : 2024-11-22 DOI:10.1186/s40621-024-00548-8

Wuraola Olawole, Guohua Li, Ziqi Zhou, Zhixing Wu, Qixuan Chen

{"title":"Impact of neighborhood-level COVID-19 mortality on the increase in drug overdose mortality in New York City during the COVID-19 pandemic.","authors":"Wuraola Olawole, Guohua Li, Ziqi Zhou, Zhixing Wu, Qixuan Chen","doi":"10.1186/s40621-024-00548-8","DOIUrl":null,"url":null,"abstract":"Background: Overdose mortality increased substantially during the COVID-19 pandemic, but it is unclear to what extent the COVID-19 mortality had contributed to this increase at the neighborhood level.Methods: This was an ecological study based on New York City United Hospital Fund (NYC UHF) neighborhood-level data from 2019 to 2021, split into two time-windows: pre-COVID (2019) and during-COVID (2020 and 2021). Linear regression models were used to estimate the effect of cumulative COVID-19 mortality on the increase in drug overdose mortality from the pre-COVD to during-COVID periods at the neighborhood level, with and without adjusting for neighborhood characteristics.Results: Drug overdose mortality rate increased from 21.3 to 33.4 deaths per 100,000 person-years across NYC UHF neighborhoods from pre-COVID to during-COVID. For each additional COVID-19 death per 1,000 person-years at the neighborhood level, the increase in drug overdose mortality rose 2.4 (95% CI: 1.7, 3.3) times. Furthermore, neighborhoods with a higher percentage of Hispanic residents, a higher percentage of single-person households, and a higher percentage of residents with health insurance experienced significantly larger increases in drug overdose mortality. In contrast, neighborhoods with a higher percentage of residents aged 75 and older had a smaller increase in drug overdose mortality.Conclusions: NYC neighborhoods with higher cumulative COVID-19 mortality experienced a greater increase in drug overdose mortality during the first two years of the COVID-19 pandemic.","PeriodicalId":37379,"journal":{"name":"Injury Epidemiology","volume":"11 1","pages":"65"},"PeriodicalIF":2.4000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11585137/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Injury Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40621-024-00548-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Overdose mortality increased substantially during the COVID-19 pandemic, but it is unclear to what extent the COVID-19 mortality had contributed to this increase at the neighborhood level.

Methods: This was an ecological study based on New York City United Hospital Fund (NYC UHF) neighborhood-level data from 2019 to 2021, split into two time-windows: pre-COVID (2019) and during-COVID (2020 and 2021). Linear regression models were used to estimate the effect of cumulative COVID-19 mortality on the increase in drug overdose mortality from the pre-COVD to during-COVID periods at the neighborhood level, with and without adjusting for neighborhood characteristics.

Results: Drug overdose mortality rate increased from 21.3 to 33.4 deaths per 100,000 person-years across NYC UHF neighborhoods from pre-COVID to during-COVID. For each additional COVID-19 death per 1,000 person-years at the neighborhood level, the increase in drug overdose mortality rose 2.4 (95% CI: 1.7, 3.3) times. Furthermore, neighborhoods with a higher percentage of Hispanic residents, a higher percentage of single-person households, and a higher percentage of residents with health insurance experienced significantly larger increases in drug overdose mortality. In contrast, neighborhoods with a higher percentage of residents aged 75 and older had a smaller increase in drug overdose mortality.

Conclusions: NYC neighborhoods with higher cumulative COVID-19 mortality experienced a greater increase in drug overdose mortality during the first two years of the COVID-19 pandemic.

查看原文本刊更多论文

在 COVID-19 大流行期间，邻里一级 COVID-19 死亡率对纽约市吸毒过量死亡率增长的影响。

背景：在 COVID-19 大流行期间，用药过量死亡率大幅上升，但目前尚不清楚 COVID-19 在多大程度上导致了社区层面的死亡率上升：这是一项基于纽约市联合医院基金（NYC UHF）2019 年至 2021 年邻里层面数据的生态研究，分为两个时间窗口：COVID 前（2019 年）和 COVID 期间（2020 年和 2021 年）。我们使用线性回归模型来估算 COVID-19 的累积死亡率对从 COVD 前到 COVID 期间邻近地区吸毒过量死亡率增加的影响，包括调整和不调整邻近地区特征：从 COVID 前到 COVID 期间，纽约市超高频社区的吸毒过量死亡率从每 10 万人年 21.3 例增加到 33.4 例。在社区层面，每增加 1,000 人-年的 COVID-19 死亡人数，吸毒过量死亡率就会增加 2.4 倍（95% CI：1.7, 3.3）。此外，在西班牙裔居民比例较高、单身家庭比例较高和拥有医疗保险的居民比例较高的社区，吸毒过量死亡率的增幅明显更大。相比之下，75 岁及以上居民比例较高的社区吸毒过量死亡率增幅较小：结论：在 COVID-19 大流行的头两年，COVID-19 累积死亡率较高的纽约市街区的吸毒过量死亡率增幅较大。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Injury Epidemiology Medicine-Medicine (all)

CiteScore

3.20

自引率

4.50%

发文量

审稿时长

13 weeks

期刊介绍： Injury Epidemiology is dedicated to advancing the scientific foundation for injury prevention and control through timely publication and dissemination of peer-reviewed research. Injury Epidemiology aims to be the premier venue for communicating epidemiologic studies of unintentional and intentional injuries, including, but not limited to, morbidity and mortality from motor vehicle crashes, drug overdose/poisoning, falls, drowning, fires/burns, iatrogenic injury, suicide, homicide, assaults, and abuse. We welcome investigations designed to understand the magnitude, distribution, determinants, causes, prevention, diagnosis, treatment, prognosis, and outcomes of injuries in specific population groups, geographic regions, and environmental settings (e.g., home, workplace, transport, recreation, sports, and urban/rural). Injury Epidemiology has a special focus on studies generating objective and practical knowledge that can be translated into interventions to reduce injury morbidity and mortality on a population level. Priority consideration will be given to manuscripts that feature contemporary theories and concepts, innovative methods, and novel techniques as applied to injury surveillance, risk assessment, development and implementation of effective interventions, and program and policy evaluation.